Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.810
+0.080 (+4.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024
August 14, 2024
bioAffinity Technologies just reported results for the second quarter of 2024.
Via
InvestorPlace
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
August 14, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Crude Oil Falls Sharply; Exxon Mobil Earnings Top Views
August 02, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Tumbles 3%; US Economy Adds 114,000 Jobs In July
August 02, 2024
Via
Benzinga
Topics
Economy
Exposures
Economy
Dow Dips Over 400 Points; Apple Posts Upbeat Earnings
August 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 12, 2024
Via
ACCESSWIRE
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
July 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 05, 2024
Via
ACCESSWIRE
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024
May 15, 2024
bioAffinity Technologies just reported results for the first quarter of 2024.
Via
InvestorPlace
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies News Update
May 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 24, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023
April 01, 2024
bioAffinity Technologies just reported results for the fourth quarter of 2023.
Via
InvestorPlace
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
Exposures
Product Safety
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
March 06, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 06, 2024
Via
Benzinga
Why BioAffinity Technologies (BIAF) Shares Are Down 50%
March 06, 2024
BioAffinity Technologies shares are trading lower by 50.7% during Wednesday's session. The company announced a securities purchase agreement with institutional investors.
Via
Benzinga
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
March 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.